Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. 1983

R Badaró, and S G Reed, and E M Carvalho

This study was designed to determine which morphologic form and species of Leishmania is most suitable for detection of antibody in sera from American visceral leishmaniasis (AVL) patients by the indirect fluorescent antibody test (IFAT). Promastigotes and amastigotes of Leishmania mexicana or Leishmania donovani chagasi were used as sources of antigen. A total of 70 sera, including 30 from AVL patients, 30 from healthy subjects and 10 from Chagas' disease patients, were used in the study. Titers of antibody up to a dilution of 1:64 were found with all four antigens. At a titer of 1:128, the sensitivity of the IFAT using L. d. chagasi promastigotes as a source of antigen was 100% and the specificity at a titer of 1:32 was 98%. Although the sensitivity of the amastigote forms was close to 100% at a similar titer, the specificity at a titer of 32 using the L. d. chagasi amastigotes was 91% and using L. mexicana amastigotes was only 80%. The L. d. chagasi promastigote antigen was also the one that showed less cross reaction with sera from Chagas' disease patients. Since cross reactivity between Trypanosoma cruzi and Leishmania species is well known in serological tests, and minimizing of such cross reactivity is of critical importance for diagnosis, we suggest that L. d. chagasi promastigotes should be the antigen of choice for diagnosis of visceral leishmaniasis by IFAT in areas also endemic for trypanosomiasis.

UI MeSH Term Description Entries
D007891 Leishmania A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi. Leishmania (Leishmania),Leishmania (Viannia),Leishmania leishmania,Leishmania viannia,Leishmania leishmanias,Leishmania viannias,Leishmanias,Leishmanias (Leishmania),Leishmanias (Viannia),leishmanias, Leishmania,viannias, Leishmania
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American

Related Publications

R Badaró, and S G Reed, and E M Carvalho
July 2010, Tropical medicine & international health : TM & IH,
R Badaró, and S G Reed, and E M Carvalho
January 1967, Revista do Instituto de Medicina Tropical de Sao Paulo,
R Badaró, and S G Reed, and E M Carvalho
January 1993, Archives de l'Institut Pasteur de Tunis,
R Badaró, and S G Reed, and E M Carvalho
January 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene,
R Badaró, and S G Reed, and E M Carvalho
January 1968, Revista do Instituto de Medicina Tropical de Sao Paulo,
R Badaró, and S G Reed, and E M Carvalho
September 1999, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
R Badaró, and S G Reed, and E M Carvalho
October 1972, American journal of clinical pathology,
R Badaró, and S G Reed, and E M Carvalho
January 1993, Bulletin de la Societe de pathologie exotique (1990),
R Badaró, and S G Reed, and E M Carvalho
November 2013, Clinical and vaccine immunology : CVI,
R Badaró, and S G Reed, and E M Carvalho
January 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!